| Bioactivity | CDK9-IN-26 (compound 1is a CDK9 inhibitor (IC50=0.18 μM)。[1]. |
| Target | IC50: 0.18 μM (CDK9) |
| In Vivo | CDK9-IN-26 (compound 1d) |
| Name | CDK9-IN-26 |
| Formula | C17H14N4O2 |
| Molar Mass | 306.32 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Alsfouk AA, et al. New Imadazopyrazines with CDK9 Inhibitory Activity as Anticancer and Antiviral: Synthesis, In Silico, and In Vitro Evaluation Approaches. Pharmaceuticals (Basel). 2023 Jul 18;16(7):1018. |